Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis

Shock

Volumn 30, Issue 1, 2008, Pages 36-42

  Clark, Jessica A ^a   Clark, Andrew T ^a   Hotchkiss, Richard S ^a   Buchman, Timothy G ^a   Coopersmith, Craig M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bid; Cecal Ligation and puncture; EGF; FADD; Intestine; Proliferation; Villus

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN BID; RECOMBINANT EPIDERMAL GROWTH FACTOR; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE MUCOSA; LAPAROTOMY; MORTALITY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CECUM; DISEASE MODEL; DRUG EFFECT; LIGATION; PATHOPHYSIOLOGY; PUNCTURE;

ANIMALS; APOPTOSIS; CECUM; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE MODELS, ANIMAL; EPIDERMAL GROWTH FACTOR; INTESTINES; LIGATION; MICE; PUNCTURES; SEPSIS;

EID: 51549100691     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31815D0820     Document Type: Article

References (38)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1244-1250, 2007.
3. Clark JA, Coopersmith CM: Intestinal crosstalkVa new paradigm for understanding the gut as the "motor" in critical illness. Shock 28:384-393, 2007.
4. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA: Post-injury multiple organ failure: the role of the gut. Shock 15:1-10, 2001.
5. Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 141:537-561, 1974.
6. Hall PA, Coates PJ, Ansari B, Hopwood D: Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 107: 3569-3577, 1994.
7. Coopersmith CM, Stromberg PE, Davis CG, Dunne WM, Amiot DM, Karl IE, Hotchkiss RS, Buchman TG: Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 31:1630-1637, 2003.
8. Potoka DA, Upperman JS, Zhang XR, Kaplan JR, Corey SJ, Grishin A, Zamora R, Ford HR: Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol 285:G861YG869, 2003.
9. Cinel I, Buyukafsar K, Cinel L, Polat A, Atici S, Tamer L, Oral U: The role of poly(adp-ribose) synthetase inhibition in preventing endotoxemia-induced intestinal epithelial apoptosis. Pharmacol Res 46:119-127, 2002.
10. Coopersmith CM, Chang KC, Swanson PE, Tinsley KW, Stromberg PE, Buchman TG, Karl IE, Hotchkiss RS: Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 30: 195-201, 2002.
11. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287:1716-1721,2002.
12. Playford RJ, Wright NA: Why is epidermal growth factor present in the gut lumen? Gut 38:303-305, 1996.
13. Tepperman BL, Soper BD: Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat. Regul Pept 50:13-21, 1994.
14. Clark JA, Lane RH, Maclennan NK, Holubec H, Dvorakova K, Halpern MD, Williams CS, Payne CM, Dvorak B: Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288:G755YG762, 2005.
15. Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, Dvorak K, Boitano SA, Dvorak B: Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 291:G938YG949, 2006.
16. Berlanga J, Lodos J, Lopez-Saura P: Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents. Burns 28:435-442, 2002.
17. Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, Stepankova R, Payne CM, McCuskey RS: Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 282:G156YG164, 2002.
18. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335, 1983.
19. Shin CE, Helmrath MA, Falcone RA Jr, Fox JW, Duane KR, Erwin CR, Warner BW: Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration. J Surg Res 77:11-16, 1998.
20. Vyas D, Robertson CM, Stromberg PE, Martin JR, Dunne WM, Houchen CW, Barrett TA, Ayala A, Perl M, Buchman TG, Coopersmith CM: Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol 22:623-630, 2007.
21. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
22. Abud HE, Watson N, Heath JK: Growth of intestinal epithelium in organ culture is dependent on EGF signalling. Exp Cell Res 303:252-262, 2005.
23. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R: Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376:337-341, 1995.
24. Wiley HS: Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res 284:78-88, 2003.
25. Bernal NP, Stehr W, Coyle R, Erwin CR, Warner BW: Epidermal growth factor receptor signaling regulates Bax and Bcl-w expression and apoptotic responses during intestinal adaptation in mice. Gastroenterology 130:412-423, 2006.
26. Knott AW, Juno RJ, Jarboe MD, Zhang Y, Profitt SA, Thoerner JC, Erwin CR, Warner BW: EGF receptor signaling affects bcl-2 family gene expression and apoptosis after massive small bowel resection. J Pediatr Surg 38: 875-880, 2003.
27. Tafani M, Karpinich NO, Hurster KA, Pastorino JG, Schneider T, Russo MA, Farber JL: Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition. J Biol Chem 277:10073-10082, 2002.
28. Tafani M, Karpinich NO, Hurster KA, Pastorino JG, Schneider T, Russo MA, Farber JL: Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition. J Biol Chem 277:10073-10082, 2002.
29. Ethier C, Raymond VA, Musallam L, Houle R, Bilodeau M: Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein. Am J Physiol Gastrointest Liver Physiol 285: G298YG308, 2003.
30. Tibbetts MD, Zheng L, Lenardo MJ: The death effector domain protein family: regulators of cellular homeostasis. Nat Immunol 4:404-409, 2003.
31. Park SM, Schickel R, Peter ME: Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 17:610-616, 2005.
32. Zhang J, Zhang D, Hua Z: FADD and its phosphorylation. IUBMB Life 56: 395-401, 2004.
33. Sheng G, Bernabe KQ, Guo J, Warner BW: Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression. Gastroenterology 131:153-164, 2006.
34. Stehr W, Bernal NP, Erwin CR, Bernabe KQ, Guo J, Warner BW: Roles for p21waf1/cip1 and p27kip1 during the adaptation response to massive intestinal resection. Am J Physiol Gastrointest Liver Physiol 290:G933YG941, 2006.
35. Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, Pothoulakis C, Lamont JT: Clostridium difficile toxin AYinduced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 129:1875-1888, 2005.
36. Nuntharatanapong N, Chen K, Sinhaseni P, Keaney JF Jr: EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis. Am J Physiol Heart Circ Physiol 289:H99YH107, 2005.
37. Cohen S: The epidermal growth factor (EGF). Cancer 51:1787-1791, 1983.
38. Ramzy PI, Wolf SE, Irtun O, Hart DW, Thompson JC, Herndon DN: Gut epithelial apoptosis after severe burn: effects of gut hypoperfusion. J Am Coll Surg 190:281-287, 2000.